What is CEAT?

Resonance Response Test

We have treated approximately 4,000 cancer patients over the past 11 years, since 2001. From the outset, we formulated a hypothesis that cancer energy is an important contributory factor in cancer relapse and metastasis. To examine this hypothesis, we tested various cancer energy detection methods, and eventually adopted the Bi-Digital O-Ring Test (BDORT) developed by Dr. Omura Yoshiaki, a professor at New York Medical College. Resonance response is a phenomenon first reported some time ago, and occurs when there is a specific substance within the body and that same substance is brought close to the outside of the body; this will be explained in more detail below. BDORT is a screening method which uses the human as a bio-sensor; it detects the information within a living body by means of measuring the changes in finger muscle strength caused by resonance response. We verified that BDORT allowed us to detect substances in the body, even to the level of minute particles, from outside the body with great accuracy and ease (1).
     We then considered what methods could be used to detect the presence of cancer through a BDORT resonance response test, and were able to gradually improve the accuracy of those methods. We performed resonance response tests on a large number of cancers diagnosed by methodologies of conventional medicine (CM). As a result, we were able to confirm that the response of the same cancer spread around the region where the cancer was discovered. Our hypothesis was that that which was spreading on and around the carcinoma was cancer energy. This cancer energy cannot be detected by any CM device. By contrast, the resonance response test is able to detect the presence of oncogens and cancer cell adhesion factors (integrins) even at the lowest quantities, thereby allowing it to confirm the presence of cancer at its earliest stage.
     The BDORT revealed that, in some patients, cancer can cause a number of symptoms, including weariness, persistent coughing, bloody discharge, and pain, to appear at the invisible stage, before it is discovered by CM methodology. When these patients are screened using BDORT, they invariably exhibit a response corresponding to cancer of an internal organ. Thus, CUP can also be detected easily using the BDORT.
     The BDORT used to screen for cancer energy is conducted with 3 parties: the examiner, the mediator and the patient. The mediator brings the metal rod holding the cancer parameters close to the surface of the affected bodily regions of the patient and irradiates those regions using a laser beam. Resonance response is produced in those cases where the patient’s cancer corresponds to the parameter being held close to the affected bodily area at that time, causing the mediator’s finger muscles to relax. In such cases, the relevant regions are diagnosed as having the same cancer as the parameter. For parameters, Oncogen CfosAb2 and Integrin α5 β1 at different concentrations are used to search for the presence of cancer, and pathological slides of various cancers are used to identify organ cancers.
     Despite resonance response being the subject of research for a considerable period, the true nature of resonance response has yet to be elucidated. Here, we give an outline of research conducted on resonance response to date.
     Nishizawa et al. first started working on a resonance response method using a laser, as an attempt to detect the purity of substances by electronic means, from around 1957. Later, from around 1963, cancer detection methods using Teraheltz (THz) were the subject of much research. Toru Kurabayashi, a professor at Akita University, succeeded in determining the purity of cashmere using Gallium THz, but the transmittance of THz waves by various tissues reflects not only the cell density but also the tissue components or conditions, and as such the low transmittance area of the THz image did not always coincide with that of cancer (2).
     In the meantime, at the beginning of the 20th century, Albert Abrams M. D., a professor of Stanford University, discovered that changes inside the living body could be detected by changes in percussive tones caused by muscular tension and relaxation. In the latter half of 1970s, a German engineer named Paul Schmidt verified that every disease has its own eigenfrequency, a theory based on many years of studies with multiple medical doctors. In the latter half of 1970s, Professor Yoshiaki Omura ofNew YorkMedicalCollege proved there to be an intermolecular resonance response through body muscle reflex, and succeeded in detecting and quantifying abnormalities in the body by examining subtle changes of finger strength. Professor Omura named this test the Bi-Digital O-Ring Test (BDORT), and obtained a patent in theUS. in 1993. Nowadays, BDORT is widely recognized all over the world, and is applied in medical treatment in a great number of cases.
     The BDORT-based resonance response test reveals various phenomena that are taking place in the patient’s body during the invisible stage of cancer, which cannot be detected by CM methodology. For instance, BDORT can confirm the presence of cancer energy in those cases where cancer energy at the invisible stage increases the level of tumor markers present in the body at an early stage. Furthermore, we have observed many cases where the BDORT resonance response test was able to identify cancer energy as the cause of symptoms experienced by patients complaining of such symptoms as weariness, persistent cough, bloody discharge, pain, aphonia and weakened eyesight, the causes of which CM metholodies were not able to identify. Thus, CUP refers to those cancers where the tumors that are discovered at visible stages are being caused by the cancer energy of the primary lesion, which itself remains at the invisible stage.
     What produces this phenomenon of CUP? Cancer DNA oscillates abnormally, and these oscillations are transmitted through pathways with the least resistance, causing the abnormal oscillation of the DNA of those organ cells with a predilection for cancer. This can be considered the initial step of metastasis. In the case of CUP, therefore, the wavelength of the cancer energy of the carcinoma in the metastatic region is identical to that of the primary lesion. This is consistent with Paul Schmidt’s wavelength theory. Accordingly, when BDORT is performed, by holding tissue preparations of various organ cancers toward the metastatic regions of the CUP, there is always a preparation that resonates, enabling identification of the primary lesion.
     Once a cancer cell is formed, it starts to divide and generate cancer energy. During the process of this invisible stage, this cancer energy grows to be enormous, and can sometimes cause various symptoms as mentioned earlier. These symptoms naturally cannot be detected by CM examinations. Cancer energy spreads from invisible areas to visible areas, and those cases where organ cancers of the same wavelength exist in both visible and invisible areas are deemed to be CUP.
     The use of BDORT enables us to detect primary cancer legions within 5 minutes, at a low cost and with high reliability. If treatment is started immediately upon discovery, the cancer can be cured completely within a short time. In addition, BDORT can easily identify the range of cancer energy expansion, which is the cause of postoperative relapse and metastasis. Destruction of this cancer energy can substantially reduce the likelihood of relapse and metastasis.

1.Omura Y ed:“Bi-Digital O-Ring Test molecular identification and localization method” and its application in imaging of internal organs and malignant tumors aswell as identification and localization of neurotransmitters and microorganisms –part1. Acupuncture & Electro-Therapeutics Res. Int J. 11:65-100,1986
2.Miura Y, Kamataki A,Uzeki M, Uzuku M. Sasaki T, Nishizawa J.et al. Terahertz-Wave Spectroscopy for Precise Histopathological Imaging of Tumor and Non-tumor Lesion in Paraffin Sections. Tohoku J. Exp.Med.,2011,223 291-296